NYT article on orforglipron phase 3 trial and Eli Lilly's plan to seek FDA approval in 2025

keangkong · Aug 7, 2025

The New York Times published an article entitled "Pill Causes Major Weight Loss in Eli Lilly Trial’s Results - The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year." The link does not contained a paywall: https://www.nytimes.com/2025/08/07/...e_code=1.cU8.0ZE_.OkbPmccYcUDX&smid=url-share

Calm Logic · Aug 7, 2025

"Eli Lilly will not be announcing a price for orforglipron before it is approved for marketing."

keangkong · Aug 7, 2025

Calm Logic said:
"Eli Lilly will not be announcing a price for orforglipron before it is approved for marketing."

I doubt Eli Lilly will set a price less than it charges for Zepbound and Mounjaro.

NYT article on orforglipron phase 3 trial and Eli Lilly's plan to seek FDA approval in 2025

keangkong

GLP-1 Specialist

Calm Logic

GLP-1 Specialist

keangkong

GLP-1 Specialist

Trending Topics

Latest Posts

Members Online

Forum Statistics

Share This Page!